PURPOSE: We conducted a case-parent triad study evaluating the role of maternal and offspring genotypes in the folate metabolic pathway on childhood acute lymphoblastic leukemia (ALL) risk. METHODS: Childhood ALL case-parent triads (n = 120) were recruited from Texas Children's Hospital. DNA samples were genotyped using the Sequenom iPLEX MassARRAY for 68 tagSNPs in six folate metabolic pathway genes (MTHFR, MTRR, MTR, DHFR, BHMT, and TYMS). Log-linear modeling was used to examine the associations between maternal and offspring genotypes and ALL. RESULTS: After controlling for the false discovery rate (<0.1), there were 20 significant maternal effects in the following genes: BHMT (n = 3), MTR (n = 12), and TYMS (n = 5). For instance, maternal genotypes for BHMT rs558133 (relative risk [RR] = 0.51, 95 % confidence interval [CI]: 0.30-0.87, p = 0.008, Q = 0.08) and MTR rs2282369 (RR = 0.46, 95 % CI: 0.27-0.80, p = 0.004, Q = 0.08) were associated with ALL. There were no significant offspring effects after controlling for the false discovery rate. CONCLUSIONS: This is one of the few studies conducted to evaluate maternal genetic effects in the context of childhood ALL risk. Furthermore, we employed a family-based design that is less susceptible to population stratification bias in the estimation of maternal genetic effects. Our findings suggest that maternal genetic variation in the folate metabolic pathway is relevant in the etiology of childhood ALL. The observed maternal genetic effects support the need for continued research of how the uterine environment may influence risk of ALL.
PURPOSE: We conducted a case-parent triad study evaluating the role of maternal and offspring genotypes in the folate metabolic pathway on childhood acute lymphoblastic leukemia (ALL) risk. METHODS: Childhood ALL case-parent triads (n = 120) were recruited from Texas Children's Hospital. DNA samples were genotyped using the Sequenom iPLEX MassARRAY for 68 tagSNPs in six folate metabolic pathway genes (MTHFR, MTRR, MTR, DHFR, BHMT, and TYMS). Log-linear modeling was used to examine the associations between maternal and offspring genotypes and ALL. RESULTS: After controlling for the false discovery rate (<0.1), there were 20 significant maternal effects in the following genes: BHMT (n = 3), MTR (n = 12), and TYMS (n = 5). For instance, maternal genotypes for BHMTrs558133 (relative risk [RR] = 0.51, 95 % confidence interval [CI]: 0.30-0.87, p = 0.008, Q = 0.08) and MTR rs2282369 (RR = 0.46, 95 % CI: 0.27-0.80, p = 0.004, Q = 0.08) were associated with ALL. There were no significant offspring effects after controlling for the false discovery rate. CONCLUSIONS: This is one of the few studies conducted to evaluate maternal genetic effects in the context of childhood ALL risk. Furthermore, we employed a family-based design that is less susceptible to population stratification bias in the estimation of maternal genetic effects. Our findings suggest that maternal genetic variation in the folate metabolic pathway is relevant in the etiology of childhood ALL. The observed maternal genetic effects support the need for continued research of how the uterine environment may influence risk of ALL.
Authors: Jingrong Yan; Ming Yin; ZoAnn E Dreyer; Michael E Scheurer; Kala Kamdar; Qingyi Wei; M Fatih Okcu Journal: Pediatr Blood Cancer Date: 2011-04-14 Impact factor: 3.167
Authors: Catherine Metayer; Ghislaine Scélo; Anand P Chokkalingam; Lisa F Barcellos; Melinda C Aldrich; Jeffrey S Chang; Neela Guha; Kevin Y Urayama; Helen M Hansen; Gladys Block; Vincent Kiley; John K Wiencke; Joseph L Wiemels; Patricia A Buffler Journal: Cancer Causes Control Date: 2011-07-12 Impact factor: 2.506
Authors: Christine F Skibola; Martyn T Smith; Alan Hubbard; Barry Shane; Abby C Roberts; Graham R Law; Sara Rollinson; Eve Roman; Raymond A Cartwright; Gareth J Morgan Journal: Blood Date: 2002-05-15 Impact factor: 22.113
Authors: Amy L Sherborne; Kari Hemminki; Rajiv Kumar; Claus R Bartram; Martin Stanulla; Martin Schrappe; Eleni Petridou; Agnes F Semsei; Csaba Szalai; Daniel Sinnett; Maja Krajinovic; Jasmine Healy; Marina Lanciotti; Carlo Dufour; Stefania Indaco; Eman A El-Ghouroury; Ruchchadol Sawangpanich; Suradej Hongeng; Samart Pakakasama; Anna Gonzalez-Neira; Evelia L Ugarte; Valeria P Leal; Juan P M Espinoza; Azza M Kamel; Gamal T A Ebid; Eman R Radwan; Serap Yalin; Erdinc Yalin; Mehmet Berkoz; Jill Simpson; Eve Roman; Tracy Lightfoot; Fay J Hosking; Jayaram Vijayakrishnan; Mel Greaves; Richard S Houlston Journal: Haematologica Date: 2011-04-01 Impact factor: 9.941
Authors: Renata Canalle; Vanessa S Silveira; Carlos Alberto Scrideli; Rosane G P Queiroz; Luiz Fernando Lopes; Luiz Gonzaga Tone Journal: Leuk Lymphoma Date: 2011-04-04
Authors: Hui Lv; Shao-Yan Hu; Zhi-Zuo Du; Zong Zhai; Lan Cao; Yi-Na Sun; Jun Lu; Jie Li; Hai-Long He; Yi-Huan Chai; Yi Wang Journal: Int J Clin Exp Pathol Date: 2018-03-01
Authors: Natalie P Archer; Virginia Perez-Andreu; Michael E Scheurer; Karen R Rabin; Erin C Peckham-Gregory; Sharon E Plon; Ryan C Zabriskie; Pedro A De Alarcon; Karen S Fernandez; Cesar R Najera; Jun J Yang; Federico Antillon-Klussmann; Philip J Lupo Journal: Cancer Date: 2016-08-16 Impact factor: 6.860
Authors: Jeremy M Schraw; Teresa T Yiu; Philip J Lupo; Spiridon Tsavachidis; Rachel Rau; Melissa L Bondy; Karen R Rabin; Lanlan Shen; Michael E Scheurer Journal: PLoS One Date: 2018-05-15 Impact factor: 3.240